8:04 am Orexigen Therapeutics receives the Day 120 List of Questions regarding its NB32 MAA from the EMA Committee; co is confident that it can successfully address all of the questions posed
View todays social media effects on OREX
View the latest stocks trending across Twitter. Click to view dashboard
See who Orexigen is hiring next, click here to view
